This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Many of these causes have their equivalences to the reasons behind the sale of a company (also known as a divestiture): Liquidity: As the equity holding period matured, investors (private equity funds behind companies) will look to sell. Once a sale has been decided, the process to look for a new owner is pretty well established.
Once improved, the exit can then take place, usually in the form of another sale or an InitialPublicOffering (IPO), both of which are usually under the advice of an investment bank. You must be able to consider long-term goals, assess risk, and craft plans to enhance the value of portfolio companies.
A diversified revenue portfolio strengthens your business’s resilience and makes it more attractive to a broader range of buyers. Having well-documented processes in place not only streamlines operations but also instills confidence in potential buyers regarding the business’s sustainability post-sale.
Once improved, the exit can then take place, usually in the form of another sale or an InitialPublicOffering (IPO), both of which are usually under the advice of an investment bank. You must be able to consider long-term goals, assess risk, and craft plans to enhance the value of portfolio companies.
When a PE firm purchases a business, the intent is to grow the company substantially (through organic growth and acquisitions) and quickly (usually within three to seven years) with the goal of a successful sale, to another PE firm, a strategic buyer, or through an InitialPublicOffering (IPO).
A management team will need to show they are ambitious, switched on and ready to push the boundaries in marketing, sales and finance. 3) Aquis Stock Exchange Aquis Stock Exchange , run by NEX, allows businesses to raise capital through InitialPublicOfferings (IPOs). >See What is invoice factoring?
But it wasn’t all carve outs and concerned investors – even with the headwinds in the industry and beyond, there were still several traditional public M&A deals involving biotechnology or medical device companies, as large pharmaceutical companies continued to have cash to deploy for acquisitions. Let’s dig in.
Looming patent cliffs By 2030, more than 190 drugs will lose patent exclusivity , including 69 blockbuster drugs, putting at risk $236 billion in sales. Strategic innovation Strategic acquirers are feeling more pressure to consummate bolt-on acquisitions in order to round out their portfolios, enter new markets and fill innovation gaps.
The rise of founder-led, venture capital-backed companies in recent years has coincided with a surge of companies implementing dual-class share structures in connection with their initialpublicofferings. Voting agreements in public M&A transactions. The dual-class company’s overall leverage in the transaction.
Similarly, we expect sponsors to actively pursue carve out opportunities – like Francisco Partners’ carve out acquisition of the data and analytics assets from IBM’s Watson Health business – in 2023 as tech giants streamline their portfolios to focus on their core businesses.
If you are not aware of the fundamental private equity model, it is simple: buy (or invest in) a company, grow profits through increasing sales, cutting costs and/or add-on acquisitions, and then sell the larger, more profitable company for significantly more than it was purchased for.
By 2030, more than 190 commercial drugs will lose patent exclusivity , putting at risk $236 billion in Big Pharma sales. This approach, combining M&A and initialpublicoffering (IPO) preparations on parallel tracks, allows companies to maximize optionality in an uncertain market.
We organize all of the trending information in your field so you don't have to. Join 38,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content